Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Operating Expenses (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Operating Expenses for 13 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 1.85% year-over-year to $3.3 million, compared with a TTM value of $12.4 million through Dec 2025, down 0.79%, and an annual FY2025 reading of $12.4 million, down 4.62% over the prior year.
  • Operating Expenses was $3.3 million for Q4 2025 at Neuroone Medical Technologies, up from $2.9 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $6.1 million in Q2 2021 and bottomed at $2.4 million in Q1 2021.
  • Average Operating Expenses over 5 years is $3.3 million, with a median of $3.2 million recorded in 2022.
  • The sharpest move saw Operating Expenses plummeted 55.19% in 2022, then skyrocketed 36.26% in 2023.
  • Year by year, Operating Expenses stood at $2.8 million in 2021, then increased by 15.15% to $3.2 million in 2022, then rose by 13.31% to $3.7 million in 2023, then dropped by 12.06% to $3.2 million in 2024, then rose by 1.85% to $3.3 million in 2025.
  • Business Quant data shows Operating Expenses for NMTC at $3.3 million in Q4 2025, $2.9 million in Q3 2025, and $2.8 million in Q2 2025.